Two River Bancorp (TRCB) EPS Estimated At $0.30; 10 Analysts Bullish Pacira Pharmaceuticals, Inc. (PCRX)

April 10, 2018 - By Linda Rogers

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) Logo

Analysts expect Two River Bancorp (NASDAQ:TRCB) to report $0.30 EPS on April, 24.They anticipate $0.09 EPS change or 42.86% from last quarter’s $0.21 EPS. TRCB’s profit would be $2.56M giving it 14.73 P/E if the $0.30 EPS is correct. After having $0.24 EPS previously, Two River Bancorp’s analysts see 25.00% EPS growth. The stock decreased 0.62% or $0.11 during the last trading session, reaching $17.68. About 5,549 shares traded. Two River Bancorp (NASDAQ:TRCB) has declined 0.23% since April 10, 2017 and is downtrending. It has underperformed by 11.78% the S&P500.

Among 22 analysts covering Pacira Pharmaceuticals (NASDAQ:PCRX), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pacira Pharmaceuticals had 102 analyst reports since July 28, 2015 according to SRatingsIntel. Nomura initiated it with “Buy” rating and $90 target in Tuesday, September 29 report. On Thursday, March 1 the stock rating was maintained by BMO Capital Markets with “Market Perform”. The rating was downgraded by Needham on Friday, February 16 to “Hold”. As per Monday, April 9, the company rating was maintained by Piper Jaffray. The stock has “Buy” rating by Canaccord Genuity on Thursday, January 4. The firm has “Sell” rating by Janney Capital given on Thursday, October 26. Bank of America upgraded Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) on Monday, August 3 to “Neutral” rating. The stock of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has “Buy” rating given on Tuesday, April 19 by Mizuho. The firm has “Hold” rating given on Monday, April 9 by Mizuho. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, February 28. See Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) latest ratings:

09/04/2018 Broker: Mizuho Rating: Hold New Target: $31.0000 Maintain
09/04/2018 Broker: H.C. Wainwright Rating: Buy New Target: $48.0000 Maintain
09/04/2018 Broker: Piper Jaffray Rating: Buy New Target: $44.0000 Maintain
08/04/2018 Broker: Seaport Global Rating: Buy New Target: $48.0000 Maintain
05/04/2018 Broker: Wedbush Rating: Buy New Target: $72.0000 Maintain
09/04/2018 Broker: Canaccord Genuity Old Rating: Hold New Rating: Hold Old Target: $32 New Target: $34 Maintain
09/04/2018 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Market Perform Old Target: $31 New Target: $34 Maintain
20/03/2018 Broker: Seaport Global Rating: Buy New Target: $42.0 Maintain
07/03/2018 Broker: Wedbush Rating: Buy New Target: $72.0 Maintain
01/03/2018 Broker: Jefferies Rating: Buy New Target: $49.0 Maintain

Since October 26, 2017, it had 0 buys, and 1 insider sale for $194,942 activity. 10,000 Two River Bancorp (NASDAQ:TRCB) shares with value of $194,942 were sold by GREGORY ROBERT E.

Investors sentiment increased to 1.62 in 2017 Q4. Its up 0.43, from 1.19 in 2017Q3. It is positive, as 1 investors sold Two River Bancorp shares while 12 reduced holdings. 6 funds opened positions while 15 raised stakes. 1.86 million shares or 0.11% more from 1.86 million shares in 2017Q3 were reported. Parallax Volatility Advisers Limited Partnership holds 0% or 1,092 shares in its portfolio. Vanguard owns 179,907 shares for 0% of their portfolio. Dimensional Fund Advisors Limited Partnership accumulated 35,843 shares. Bnp Paribas Arbitrage Sa holds 0% of its portfolio in Two River Bancorp (NASDAQ:TRCB) for 2,095 shares. Royal National Bank Of Canada reported 146 shares. Invesco Limited reported 31,801 shares or 0% of all its holdings. Banc Funds Ltd Liability holds 0.19% of its portfolio in Two River Bancorp (NASDAQ:TRCB) for 223,495 shares. 19,315 were reported by Bank Of America De. Strs Ohio has 0% invested in Two River Bancorp (NASDAQ:TRCB). Panagora Asset Mgmt stated it has 4,426 shares. Mercer Advisers holds 54,933 shares or 0.72% of its portfolio. New York State Common Retirement Fund owns 7,700 shares. Clarivest Asset Management Ltd holds 8,715 shares or 0% of its portfolio. Legal And General Group Public Limited Co holds 0% of its portfolio in Two River Bancorp (NASDAQ:TRCB) for 1,526 shares. State Street has invested 0% of its portfolio in Two River Bancorp (NASDAQ:TRCB).

Two River Bancorp operates as the bank holding firm for Two River Community Bank that provides banking services to small and medium-sized businesses, professionals, and individual consumers. The company has market cap of $150.72 million. The firm accepts deposit products, such as demand, savings, and time deposits; checking and money market accounts; and certificates of deposit. It has a 23.57 P/E ratio. The Company’s loan products include construction and land development loans; commercial and industrial loans; commercial real estate loans; residential real estate loans, such as single-family detached units, individual condominium units, two-to-four family dwelling units, and townhouses; consumer loans comprising home equity lines of credit, home equity loans, personal loans, automobile loans, and overdraft protection; participation loans; and small business administration loans.

The stock increased 3.60% or $1.2 during the last trading session, reaching $34.5. About 3.04M shares traded or 204.15% up from the average. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has declined 33.05% since April 10, 2017 and is downtrending. It has underperformed by 44.60% the S&P500.

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, makes, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. The company has market cap of $1.41 billion. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. It currently has negative earnings. The companyÂ’s lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for infiltration into the surgical site to produce postsurgical analgesia.

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>